HopeStage
Back to all studies
RecruitingNCT07145866

Varenicline and accelerated TMS to help adults stop nicotine use

About this titleRead the official source — NCT07145866
Medication studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What will I do during this study?

Participants take the medication varenicline for twelve weeks, complete questionnaires and have MRI (magnetic resonance imaging) scans. The protocol compares active accelerated transcranial magnetic stimulation with D-cycloserine against simulated stimulation with a placebo (an inactive comparison treatment); both groups take varenicline.

Listed locations
BostonSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 2, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
30
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Behavioural, Device, Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT07145866
Official title
Show the full official title

Evaluation of Varenicline and Accelerated TMS for Reduction of Nicotine Use

Recruitment & locations

Currently recruiting

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What will I need to do?

You will take study medication.

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Varenicline and D-cycloserine.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies